ADIPOQ gene polymorphisms and susceptibility to polycystic ovary syndrome: a HuGE survey and meta-analysis

Eur J Obstet Gynecol Reprod Biol. 2012 Apr;161(2):117-24. doi: 10.1016/j.ejogrb.2011.12.017. Epub 2012 Jan 11.

Abstract

Polycystic ovary syndrome (PCOS) is one of the most common female endocrine disorders. The aim of this study was to investigate possible associations between 45T/G and 276G/T variants of the ADIPOQ gene and susceptibility to PCOS. A meta-analysis of 11 published case-control studies on the 45T/G variant of the ADIPOQ gene (involving a total of 1176 patients with PCOS and 1759 controls) and eight published case-control studies on the 276G/T variant of the ADIPOQ gene (involving a total of 895 patients with PCOS and 1024 controls) was performed. Odds ratios (ORs) with 95% confidence intervals (CIs) were used to assess the strength of associations. The comparison of G vs. T in ADIPOQ 45T/G showed significant differential susceptibility to PCOS (OR=1.397, 95% CI 1.156-1.689). A significant association was also found between PCOS susceptibility and the comparison of G vs. T in ADIPOQ 276G/T (OR 0.812, 95% CI 0.704-0.937). However, protective effects were found in both sites under the co-dominant model for Caucasians. Further studies are warranted to assess these associations in greater detail, especially in Asian populations.

Publication types

  • Meta-Analysis
  • Review

MeSH terms

  • Adiponectin / genetics*
  • Asian People / genetics
  • Confidence Intervals
  • Female
  • Genetic Predisposition to Disease*
  • Humans
  • Odds Ratio
  • Polycystic Ovary Syndrome / ethnology
  • Polycystic Ovary Syndrome / genetics*
  • Polymorphism, Single Nucleotide*
  • White People / genetics

Substances

  • ADIPOQ protein, human
  • Adiponectin